R&D Systems™ Human 2B4/CD244/SLAMF4 Fc Chimera Recombinant Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Manufacturer: R&D Systems™ 10392B050
DescriptionThe Recombinant Human 2B4/CD244/SLAMF4 Fc Chimera Protein is derived from NS0. The Recombinant Human 2B4/CD244/SLAMF4 Fc Chimera Protein has been validated for the following applications: Binding Activity.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|48.8 kDa (monomer)|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|2B4/CD244/SLAMF4 Fc Chimera|
|95%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Mouse myeloma cell line,NS0-derived human 2B4/CD244/SLAMF4 protein, (N-terminus) Human 2B4 (Cys22-Arg221) Accession &Num; NP_057466 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok